Purchase Order 75N93020P00981

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $26,271.50 on April 20, 2020, for high parameter conjugates and HU CD197 antibody, with performance completed by April 19, 2021. Work is performed at Brea, California. This award was issued under the Coronavirus COVID-19 national interest action code and carries no small business set-aside.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $11,585.00 on August 4, 2020, for fifty tests each of HU CD183 BV711 1C6/CXCR3, with completion by September 3, 2020. Performance occurs in San Jose, California. The purchase order is firm fixed price with no small business set-aside. The award carries a Coronavirus COVID-19 national interest action code.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a purchase order to Becton, Dickinson And Co on March 30, 2021, for unique and distinct reagents—fluorescently conjugated monoclonal antibodies based on custom conjugates, legacy, Brilliant, and Early Access dyes—with a ceiling value of $10,578.00. Work is performed at the awardee's facility in Franklin Lakes, New Jersey. The order is firm fixed price with an ultimate completion date of April 29, 2021.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company (BD Biosciences) on May 18, 2018, with a ceiling value of $11,200 for fluorescently conjugated monoclonal antibodies for flow cytometry research and pre-clinical vaccine monitoring.</p> <p>Place of performance is San Jose, CA. The order is firm fixed price with an ultimate completion date of June 22, 2018. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a $6,050 delivery order to Becton, Dickinson And Company (BD Biosciences division) on July 16, 2018, for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates for vaccine research and pre-clinical monitoring.</p> <p>Place of performance is San Jose, CA. The order carries an ultimate completion date of August 10, 2018, and is priced on a firm fixed price basis. No set-aside was used.</p>

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson &amp; Co. (BD) for COVID-19 research antibodies and related supplies. The award ceiling is $88,595.50 and it has an ultimate completion date of August 5, 2022. This requirement was competed without a small business set-aside under FAR Simplified Acquisition Procedures, as a brand name restriction for...

<p>The National Institute of Allergy and Infectious Diseases issued a $21,515 delivery order to Becton, Dickinson and Company (BD Biosciences) on March 28, 2018, for fluorescently conjugated monoclonal antibodies and flow cytometry consumables for the Vaccine Research Center.</p> <p>Place of performance is San Jose, California. The order is firm fixed price with an ultimate completion date of April 6, 2018. No set-aside was applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $13,237.18 on October 19, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion date is January 20, 2021. The source does not specify the equipment or supplies purchased under this order.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company (BD Biosciences) on July 16, 2018, with a ceiling value of $10,335.00 for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates for vaccine research and pre-clinical monitoring.</p> <p>Place of performance is San Jose, CA. The order is firm fixed price with an ultimate completion date of August 10, 2018. No set-aside was used.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on July 5, 2019, for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates and consumables for vaccine research and pre-clinical monitoring, with a ceiling value of $6,425.00. Place of performance is San Jose, CA. Ultimate completion date is August 9, 2019. The order is priced on a firm fixed price basis and was issued without a set-aside.